TrialBioMed research international2020

Outcomes of Hypofractional Tomotherapy in Patients with Stage III Nonsmall Cell Lung Cancer Who Are Not Eligible for Surgery or Concurrent Chemoradiation.

Jing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.